Journal article
Abstract 14170: Reduction in Venous Thromboembolism With Rivaroxaban versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD
Abstract
Background:
Prior studies suggest that atherosclerotic vascular disease may be associated with risk of venous thromboembolism (VTE), though the relationship remains uncertain and has not been well-studied in peripheral artery disease (PAD) after lower extremity revascularization (LER).
Authors
Hess CN; Anand S; Bauersachs R; Patel MR; Debus ES; Nehler MR; Capell WH; Diao L; Muehlhofer E; berkowitz S
Journal
Circulation, Vol. 142, No. Suppl_3,
Publisher
Wolters Kluwer
Publication Date
November 17, 2020
DOI
10.1161/circ.142.suppl_3.14170
ISSN
0009-7322